Pharma G2N Finance Lead — Forecasting & Analysis

TriOptus LLC; East Hanover (NJ); Hybrid; USD 120,000 - 180,000; Full time

Job summary

TriOptus LLC in East Hanover, NJ, is seeking a Senior Finance Expert - Gross to Net (G2N) on a hybrid, 6-7 month contract. The role partners with commercial teams to forecast G2N, perform variance analysis, and provide leadership-ready insights.

You will maintain data in Breakaway G2N and Breakaway software, build Excel-based models, and deliver timely forecast updates and risk assessments to support senior management decisions. 4+ years in pharma G2N forecasting preferred.

Qualifications

• 4+ years of senior-level experience executing Gross-to-Net forecasting within a pharmaceutical company.
• Proven experience supporting forecasting, variance analysis, and leadership reporting.
• Strong operational finance and business partnering background.

Responsibilities

• Provide day-to-day operational support for G2N forecasting and variance analysis.
• Ensure data integrity from commercial teams and deliver insights to improve forecast accuracy.
• Update Breakaway G2N system with refreshed assumptions and data; leverage Excel models for G2N rates.
• Prepare and present G2N materials for monthly reviews and senior leadership meetings.
• Support governance with document minutes and action tracking for forecast reviews.

Skills

Gross-to-Net forecasting

Pharma finance

Financial modeling

Analytical thinking

Business partnering

Communication skills

Tools

Breakaway G2N system

Breakaway application

Excel

Job description

TriOptus LLC in East Hanover, NJ, is seeking a Senior Finance Expert - Gross to Net (G2N) on a hybrid, 6-7 month contract. The role partners with commercial teams to forecast G2N, perform variance analysis, and provide leadership-ready insights.

You will maintain data in Breakaway G2N and Breakaway software, build Excel-based models, and deliver timely forecast updates and risk assessments to support senior management decisions. 4+ years in pharma G2N forecasting preferred.